Patent · US Active

Dezocine analogue

US10414718B2 · kind B2 · utility

1Cited by
12References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 4, 2017
Grant dateSep 17, 2019
Priority date
Expiry dateJan 4, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2603/80
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed in the present disclosure is a Dezocine analog, and particularly disclosed are compounds represented by formula (I), (II) and (III), a pharmaceutically acceptable salt or tautomer thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.